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Abstract The simple and effective technique of fission
track etch has been applied to determine trace concentration
of uranium in human blood samples taken from two groups
of male and female participants: leukemia patients and
healthy subjects group. The blood samples of leukemia
patients and healthy subjects were collected from three key
southern governorates namely, Basrah, Muthanna and Dhi-
Qar. These governorates were the centers of intensive mili-
tary activities during the 1991 and 2003 Gulf wars, and the
discarded weapons are still lying around in these regions.
CR-39 track detector was used for registration of induced
fission tracks. The results show that the highest recorded
uranium concentration in the blood samples of leukemia
patients was 4.71 ppb (female, 45 years old, from Basrah)
and the minimum concentration was 1.91 ppb (male, 3 years
old, from Muthanna). For healthy group, the maximum
uranium concentration was 2.15 ppb (female, 55 years old,
from Basrah) and the minimum concentration was 0.86 ppb
(male, 5 years old, from Dhi-Qar). It has been found that the
uranium concentrations in human blood samples of leukemia
patients are higher than those of the healthy group. These
uranium concentrations in the leukemia patients group were
significantly different (P \ 0.001) from those in the healthy
group.
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Introduction
Uranium is one of the most serious contamination concerns
because of its radioactivity and heavy-metal toxicity. Ura-
nium and its compounds are highly toxic, which is a threat to
human health and ecological balance [1]. Uranium is wide-
spread in nature, and it exists in the form of solid, liquid, and
gaseous compounds. It readily combines with other elements
to form uranium oxide, silicates, carbonates, and hydroxides
[2]. Uranium is used as fuel in nuclear power plants and is
present, in the different steps of the nuclear industry, in
different forms with different isotopic compositions (natural,
depleted, and enriched). Depleted uranium (DU) is a
byproduct of the nuclear industry. Its specific activity is
approximately 40 % lower than that of naturally occurring
uranium. Because of its high density and metallurgical
properties, DU is used in the manufacture of armor and armor
piercing shells in several countries [3, 4]. The first use of DU
was in the Gulf war in 1991 [5]. In the south of Iraq, DU was
and still an environmental pollution problem because its
levels raised after both Gulf wars I and II in 1991 and 2003
respectively [6].
There are different possible ways by which uranium can
reach the human body either in a direct way by inhaling
uranium-bearing dust particles or by drinking water which
is polluted by uranium, or in an indirect way from the
fertile soil layer via the food chain [7]. Solubility of ura-
nium varies depending on the particular compounds and
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the solvent, and this solubility determines how quickly and
efficiently the body absorbs them through the lungs and the
intestines, respectively [8].Uranium deposited in the bones
and other organs is subsequently released back into the
blood stream, which causes several health problems rang-
ing from cancer to kidney failure, leukemia, respiratory
disorders, congenital abnormalities, skin diseases, and
other obscure unknown diseases [9–11].
Researchers at the Armed Forces Radiobiology
Research Institute (AFRRI) in Bethesda and others have
found that uranium causes mutations in DNA [12, 13] and
uranium exposure can result in increased chromosomal
aberrations [14–16]. It is a widely accepted principle in
molecular biology that agents that cause mutations or
damage DNA can cause cancer.
In Iraq, the incidence of cancers that are registered annu-
ally by Iraqi Cancer Board involved an increase in the number
of cancer cases that are recorded after the Gulf wars [17].
There are some areas in the southern of Iraq like (Bas-
rah, Muthanna and Dhi-Qar) that have experienced a
twofold to fivefold increase in reported cancers. Most of
these cases involve damage to the lungs, bronchial tubes,
bladder, and skin. In addition, an increased incidence of
stomach cancer in males and breast cancer in females has
also been reported, as well as an overall increase in leu-
kemia cases [18].
Solid-state nuclear track detectors (SSNTDs) are nor-
mally used to determine the uranium concentration in
human blood [10, 11]. The fission track technique was
suggested by Fleischer et al. [19] who proposed the method
of using thermal neutron irradiation of solid-state track-
recording materials that are in contact with both films and
pressed together to dry the blood. This technique appears
particularly suitable for quantitative determination of ura-
nium in the blood.
The aim of this study is to determine the uranium con-
centration in the blood of the leukemia patients and the
healthy group using CR-39 nuclear track detector.
Material and method
Sample collection
In this study, 60 blood samples of volunteers, males and
females, were collected from two groups. The first group
included the leukemia patients by which 30 blood samples
were collected from hospitals in Basrah, Muthanna and Dhi-
Qar. While the second group involved the healthy volunteers
and the samples were gathered from 30 healthy volunteers who
live in these governorates in the southern of Iraq Fig. 1. The
volunteers from these groups had no previous history of
occupational exposure to uranium. They completed a com-
prehensive questionnaire about demographic information such
as age, gender, and medical history. The ratio between the
genders for these groups was more balanced Table 1.
Experimental method
The experimental technique for the investigation of ura-
nium concentration is the same as reported elsewhere [10,
11, 21, 22].
Blood samples were heated at 37 C for 24 h using an
electric heating incubator to dry and to oxidize organic
material. The powders collected in the form of 0.5 g of
dried powder blood were mixed with 0.1 g of methylcel-
lulose (C6 H10 O5) used as a binder. The mixture was
pressed into a pellet of 1 cm diameter and 1.5 mm thick-
ness. The pellets were covered with CR-39 track detector
on both sides and were put in a plate of paraffin wax at a
distance of 5 cm from Am–Be neutron source with a
thermal flounce equal to (3.024 9 109 n cm-2) for 7 days,
to cause latent damage to the detector due to 235U (n, f)
reaction.
After the irradiation, the CR-39 detectors were etched in
(N = 6.25) NaOH solution at temperature of 60 C for 5 h.
The induced fission tracks densities were recorded using
Olympus optical microscope with magnification of 4009 .
The fission track densities were measured on the surfaces,
showing uniform distribution of uranium.
Calculations
The investigation into the uranium concentration in the
blood samples was carried out by comparing between the
densities of track registered on CR-39 detectors around the
sample pellet and that of standard samples pellet, via the
following relation [10, 23]:
Ux ¼ Usqx= qs: Is=Ix: Rs= Rx ð1Þ
Where:
Ux and Us are the uranium concentration for the
unknown and the standard samples.
qx and qs are the densities of fission tracks for the
unknown and the standard samples.
Ix and Is are the isotopic abundance ratio of
235U to 238U
for the unknown and standard samples.
Rx and Rs are the range of fission fragments in mg cm
-2
for the unknown and standard samples.
The correction factor (Rs/Rx) is taken to be unity. Sim-
ilarly, taking (Is/Ix) as unity, the equation becomes
Ux ¼ Usqx= qs ð2Þ
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Statistical analysis
All the results that are obtained from all samples of the two
groups were statistically analyzed using Statistical Package
of the Social Sciences (SPSS) and the significance of the
probability level (P) was estimated by Independent sample
t Test.
Result and discussion
Table 2 shows the uranium concentration in blood samples
of the leukemia patients group. The maximum value
obtained was 4.71 ppb which belongs to a female (45 years
from Basrah), and the minimum value of the leukemia
patients group is 1.91 ppb for a male child (3 years from
Muthanna). The mean value of uranium concentration of
this group is 2.87 ppb.
Table 3 shows the uranium concentration in blood
samples of the healthy group. The maximum value
obtained was 2.15 ppb which belongs to a female (55 years
from Basrah), and the minimum value of the healthy group
is 0.86 ppb for a male child (5 years from Dhi-Qar).The
mean value of uranium concentration of this group is
1.43 ppb.
From Tables 2, 3, the mean value of uranium concentra-
tion in blood samples of the leukemia patients group was two
times higher than those of the healthy group, and this finding
is in agreement with those of other researchers [11, 23].
Fig. 1 The location of the three
governorates (Basrah, Muthanna and
Dhi-Qar) involved in the study





Number of males 14 14
Number of females 16 16
Age range/years 2–71 3–57
Average age/years (Males) 20.64 20.71
Average age/years (Females) 21.43 19.37
Average age/years (Total) 21.1 20
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The independent sample t Test confirmed statistically
significant difference in the uranium concentration between
the leukemia patients and healthy group (P \ 0.001).
The mean value of uranium concentration in blood
samples of the leukemia patients and healthy group in this
study is higher than published values with other researchers
[10, 11, 22]. The reason behind such results can be
attributed to the fact that the area of the current study
(southern Iraq) was the center of military activities during
the Gulf wars, and the DU was and still an environmental
pollution problem because its levels raised after Gulf wars,
and the contaminated places haven’t been limited or iso-
lated to stop and avoid the spreading of this radioactive
contamination. This explains reasons behind the high
concentration in the blood of children born after the Gulf
war [24].
Table 4 represents the mean value of uranium concen-
tration in the blood samples of male and female leukemia
patients group and healthy group. From this table, the mean
value of uranium concentration of male and female leu-
kemia patients group is 2.82 and 2.9 ppb respectively,
while the mean value of uranium concentration of male and
female healthy group is 1.37 and 1.48 ppb respectively.
The results showed that the average values of uranium
concentration for female patients group and healthy group
are higher than those for male patients group and healthy
group. This is because the total blood volume in females is
4–5 L, while in males is 5–6 L [25].





in (ppb) ± S.D.
1 Male 7 Basrah 2.89 ± 0.18
2 Female 6 Basrah 3.06 ± 0.21
3 Male 71 Basrah 3.11 ± 0.19
4 Female 2 Basrah 2.69 ± 0.24
5 Female 52 Basrah 3.25 ± 0.13
6 Male 7 Basrah 3.09 ± 0.21
7 Male 6 Basrah 3.04 ± 0.24
8 Male 62 Basrah 3.18 ± 0.22
9 Female 29 Basrah 3.15 ± 0.17
10 Female 45 Basrah 4.71 ± 0.17
11 Female 8 Muthanna 2.62 ± 0.21
12 Male 3 Muthanna 1.91 ± 0.24
13 Male 17 Muthanna 2.73 ± 0.20
14 Female 2 Muthanna 2.54 ± 0.21
15 Male 5 Muthanna 2.33 ± 0.13
16 Male 17 Muthanna 2.27 ± 0.12
17 Female 15 Muthanna 3.04 ± 0.11
18 Female 28 Muthanna 2.92 ± 0.18
19 Male 16 Muthanna 4.68 ± 0.17
20 Female 50 Muthanna 2.71 ± 0.15
21 Male 24 Dhi-Qar 2.22 ± 0.23
22 Female 59 Dhi-Qar 2.89 ± 0.13
23 Female 7 Dhi-Qar 3.03 ± 0.21
24 Male 15 Dhi-Qar 2.97 ± 0.25
25 Female 8 Dhi-Qar 1.98 ± 0.14
26 Female 12 Dhi-Qar 2.84 ± 0.18
27 Female 8 Dhi-Qar 2.43 ± 0.18
28 Male 11 Dhi-Qar 2.7 ± 0.18
29 Male 50 Dhi-Qar 2.45 ± 0.16
30 Female 60 Dhi-Qar 2.61 ± 0.15
Mean ± Std Error 2.87 ± 0.11





in (ppb) ± S.D.
1 Female 6 Basrah 1.41 ± 0.14
2 Male 4 Basrah 0.91 ± 0.11
3 Male 10 Basrah 0.96 ± 0.1
4 Female 15 Basrah 1.77 ± 0.14
5 Male 20 Basrah 1.73 ± 0.15
6 Male 57 Basrah 2.1 ± 0.14
7 Male 32 Basrah 2.07 ± 0.2
8 Female 55 Basrah 2.15 ± 0.25
9 Female 3 Basrah 0.92 ± 0.11
10 Female 5 Basrah 1.28 ± 0.14
11 Female 10 Muthanna 1.4 ± 0.12
12 Female 3 Muthanna 0.92 ± 0.1
13 Male 8 Muthanna 0.98 ± 0.16
14 Female 20 Muthanna 1.51 ± 0.17
15 Male 18 Muthanna 1.37 ± 0.19
16 Male 45 Muthanna 1.84 ± 0.14
17 Female 8 Muthanna 1.16 ± 0.12
18 Female 26 Muthanna 2.09 ± 0.21
19 Female 45 Muthanna 1.94 ± 0.25
20 Male 20 Muthanna 1.28 ± 0.15
21 Female 25 Dhi-Qar 1.44 ± 0.18
22 Male 5 Dhi-Qar 1.15 ± 0.26
23 Female 56 Dhi-Qar 2.1 ± 0.17
24 Male 8 Dhi-Qar 1.11 ± 0.08
25 Male 18 Dhi-Qar 1.22 ± 0.17
26 Female 14 Dhi-Qar 1.4 ± 0.21
27 Male 5 Dhi-Qar 0.86 ± 0.15
28 Female 10 Dhi-Qar 1.24 ± 0.19
29 Female 11 Dhi-Qar 1.2 ± 0.41
30 Male 38 Dhi-Qar 1.48 ± 0.17
Mean ± Std Error 1.43 ± 0.07
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Results showed no statistically significant difference in
the uranium concentration with regard to gender in both
groups (P [ 0.05).
Table 5 illustrates the average of uranium concentration
in the blood samples of the leukemia patients group and
healthy group as a function of residential place. This table
shows that the mean value of uranium concentration in
blood samples of leukemia patients group in Basrah,
Muthanna and Dhi-Qar is 3.21, 2.77 and 2.61 ppb respec-
tively, while the mean value of uranium concentration in
blood samples of healthy group in Basrah, Muthanna and
Dhi-Qar is 1.53, 1.45 and 1.32 ppb respectively. It is
obvious that the mean value of uranium concentration in
the blood samples of the patients group and healthy group
in Basrah is higher than those in Muthanna and Dhi-Qar;
because Basrah is the region which received the highest
amount of DU during the Gulf wars I and II in 1991 and
2003 respectively. Results showed statistically significant
correlation with residential area (P \ 0.05).
Conclusion
The results obtained show that uranium concentrations in
the blood samples of the leukemia patients group are higher
than those of the healthy group. These results show a direct
relation between the disease of these patients and the ura-
nium content in the blood.
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